The Beta Cell in Type 2 Diabetes | SpringerLink
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
Targeting inflammation in the treatment of type 2 diabetes: time to start | Nature Reviews Drug Discovery
Molecules | Free Full-Text | Progress in Metabonomics of Type 2 Diabetes Mellitus
IJMS | Free Full-Text | Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes | Scientific Reports
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population | Nature Communications
IJMS | Free Full-Text | Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence
IJMS | Free Full-Text | Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes
Endocrine and Metabolic Insights from Pancreatic Surgery: Trends in Endocrinology & Metabolism
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes: Molecular Therapy
Frontiers | Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population
Strategies for durable β cell replacement in type 1 diabetes | Science
Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet - ScienceDirect
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure: Cell
IJMS | Free Full-Text | Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis
Frontiers | Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
IJMS | Free Full-Text | Stem Cell-Derived Islets for Type 2 Diabetes
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress
Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure | Experimental & Molecular Medicine
Frontiers | Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
Cells | Free Full-Text | MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
JCI Insight - Human duct cells contribute to β cell compensation in insulin resistance
